HRAS and breast carcinoma: Moreover, the association of ANXA6 with H-Ras-containing protein complexes may contribute to the regulation of EGFR overexpression and p120GAP/Ras assembly in ER (−) breast cancer cells, thereby inhibiting Ras signaling in breast cancer cells [37].